James R Klinger

14PUBLICATIONS
30CO-AUTHORS
Respiratory diseasesGene and molecular therapyPharmacogenomicsMajor global burdens of diseaseEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 04, 2026
Identification of drug candidates for rescue of SOX17 gene targets in pulmonary arterial hypertension.

|May 15, 2026
Exploring the Lung-Liver Axis in Pulmonary Arterial Hypertension.

|Nov 26, 2025
Individualized Interactomes from Pulmonary Arterial Hypertension Cell Biopsies Predict Therapeutic Response.

Rui-Sheng Wang, Navneet Singh, Henri Wathieu

|Nov 17, 2025
American Lung Association Pulmonary Hypertension Roundtable: Executive Summary.

Nicholas Andreas Kolaitis, Sandeep Sahay, Erika Berman Rosenzweig

|Aug 18, 2025
Predicting Response to Switching From Phosphodiesterase Type 5 Inhibitor to Riociguat in Patients With Pulmonary Arterial Hypertension: Biomarker and Responder Analysis of the RESPITE and REPLACE Studies.

James R Klinger, Hikmet Al-Hiti, Sung-A Chang

|Aug 06, 2025
Effects of Dehydroepiandrosterone in Pulmonary Hypertension (EDIPHY): A Randomized, Double-Blind, Placebo-Controlled Crossover Trial.

Rachel Sanders, Thomas Walsh, Grayson L Baird

Pageof 3

Frequent Collaborators

3 joint publications

Olin D Liang

3 joint publications

Corey E Ventetuolo

3 joint publications

Navneet Singh

2 joint publications

Christopher J Rhodes